Scroll to top
© 2019, Joins Global Pharmaceutical Companies to Discuss Patient Data as Patient Property on Blockchain joins eyeforpharma, Sanofi Pharmaceuticals, Yale University School of Medicine and Hugo Health to discuss blockchain as Pharma’s trust catalyst to redefine the relationship between the pharmaceutical industry and patients.


Princeton, New Jersey – June 19th – (BUSINESS WIRE), a company designed to create decentralized human rights using proprietary technology and legal innovations on blockchains has been invited by Paul Simms, Chairman of eyefoprpharma to join the global pharmaceutical conversation around the impact of blockchain on the relationship between the pharmaceutical industry, patients and patient data. The four-person discussion moderated by Mr. Simms will be streamed live beginning at 09:00AM EST Wednesday June 27th 2018 with participants from Sanofi Pharmaceuticals, Hugo Health and Yale University School of Medicine.

“We are at an ethical inflection point in the use of digital and bio-technologies, AI and big data” said Jennifer E. Miller, Assistant Professor at Yale University School of Medicine and a Founder of Bioethics International. According to Dr. Miller, “People should know the data being collected, used and sold about them, especially data related to their health. Data privacy, transparency and ownership issues need to be addressed.” announced on June 12th in a joint press release with Orb Health, a leading healthcare technology company, that healthcare will be the first industry vertical where’s blockchain and legal inventions will be deployed to ensure that patient data is classified and treated patient property. “Healthcare is not the easiest industry to install trust and transparency, it was certainly not our first choice” said Richie Etwaru, Founder and CEO at However, “the industry at large is asking for a solution to help as pharmaceutical executives increasingly come to terms with the notion that re-identification of patient data is inevitable,” a regulatory violation which Mr. Etwaru asserts is a direct violation of HIPAA and GDPR. has made a strategic decision to start with the healthcare industry citing the dire need for a solution to help pharmaceutical executives avoid a potentially catastrophic regulatory crisis. has developed proprietary technology that identifies existing legal corridors in privacy-centric regulations, and has designed new intelligent contracts on blockchains which individuals such as patients can use to negotiate property-centric terms of consent and authorization with corporations.’s global inherent Human Data Consent and Authorization Blockchain (HD-CAB) is built on a “chain of chains” strategy combining Ethereum and other fabrics. Consent and authorization to use inherent human datasets – geospatial data, driver and vehicle history, consumer spending habits, medical history, and recreational habits – can now be managed transparently as legal property on a blockchain.’s blockchain-built iPhone and Android Apps launching in August 2018 can be used to help most industries classify inherent human data as human property. Healthcare organizations currently involved in the buying, selling, or use of inherent human healthcare data will be able to transition to a new trusted and transparent industry design with minimal investments and disruption by installing the global consent and authorization blockchain. Patients who download the App in August will enjoy the legal characteristics of property ownership for inherent human healthcare data, such as involvement in sale, fair market value negotiations, sharing, security, and protection from theft. This will enable patients, healthcare organizations, and the monetization of inherent human healthcare data to co-exist without regulatory violations. Healthcare organizations will enjoy blockchain-backed explicit consent and authorization to use inherent human healthcare data, and patients will enjoy greater levels of security, privacy, and control while qualifying to receive consideration via multiple forms of currency.


About is the world’s first and only organization developing human rights and corollary sovereign laws in a decentralized manner on blockchains. The company has headquarters in New Jersey, USA and operates in multiple countries. The leadership team includes over two dozen senior executives from Fortune 500 companies, academic scholars, and senior policy advisors from North America, Europe, Australia and Africa. The vision of is a world where the next generation of human rights and policies emerge from a balance of centralized power and decentralized technologically empowered communities. The mission is to create the 31st human right in a decentralized manner as an example for other organizations and visionaries to follow.



Glenn Zimmerman

Chief Communications Officer [email protected] +1.800.946.9152

We are

Watch and share video. Join the movement via #My31

We are